[Recent progress in the treatment of hematological malignancies. III. Management of patients with myelodysplastic syndromes and atypical leukemias].
Yoshida
Y
Y
D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy*
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D003561:Cytarabine; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor